Wearable AI Patch Reaches 99.6 Percent Accuracy in Detecting Heart Arrhythmias

A wearable AI patch has reached 99.6% accuracy in detecting heart arrhythmias, according to clinical testing results reported by digital health researchers in July 2026. The device continuously monitors cardiac rhythm and flags irregular patterns for physician review.

The patch is part of a broader push to bring AI-powered diagnostics out of hospital settings and into everyday life. Startups and established medical device companies are racing to develop wearables that can catch serious conditions before patients develop symptoms.

Clair Health, a startup focused on noninvasive hormone monitoring, recently raised capital to develop a wearable device that tracks hormone levels in real time. The company is targeting women's health applications, including menopause management and fertility tracking.

The FDA has been moving to keep pace with the technology. In June 2026, the agency cleared EchoNext, an AI tool developed by Pathway Labs, to detect six types of structural heart disease from a standard 12-lead ECG. The tool outperformed cardiologists in validation testing, correctly identifying 77% of structural heart problems compared to 64% for human readers.

The Fair Telehealth Billing Act of 2026, introduced in Congress, would eliminate separate facility fees for virtual care visits, which advocates say would make remote monitoring and AI-assisted diagnosis more financially accessible.

The Centers for Medicare and Medicaid Services has established an Office of Health Technology Products to oversee AI and digital health innovation, signaling that federal regulators plan to take a more active role in evaluating these tools as they move into mainstream clinical practice.

Experts say the pace of development is outrunning the regulatory frameworks designed to evaluate it, and they are calling for clearer standards around accuracy, bias testing, and real-world performance monitoring.